During the past decade, Ospedale Maggiore di Crema conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Maggiore di Crema" #1 sponsor was "European Institute of Oncology" with 2 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "Fatebenefratelli and Ophthalmic Hospital" with 1 trials sponsored, "Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy" with 1 trials sponsored and "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Maggiore di Crema" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator and "Niguarda Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Maggiore di Crema" are "Atrial Fibrillation" (1 trials), "Bladder Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Heart Failure" (1 trials) and "Hereditary Hemorrhagic Telangiectasia (HHT)" (1 trials). Many other conditions were trialed in "Ospedale Maggiore di Crema" in a lesser frequency.

Most popular intervention types in "Ospedale Maggiore di Crema" are "Drug" (6 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (2 trials), "cisplatin" (2 trials), "Docetaxel" (1 trials), "Edoxaban" (1 trials) and "Erlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Maggiore di Crema" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Maggiore di Crema". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ospedale Maggiore di Crema, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Maggiore di Crema, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".